Xeris Biopharma Holdings, Inc. is in its Mars mahadasha (8 Feb 2021 to 9 Feb 2028), Venus antardasha (3 Jan 2026 to 5 Mar 2027) and Saturn pratyantar (3 Oct 2026 to 10 Dec 2026).
Next: pratyantar Mercury from 10 Dec 2026; antardasha Sun from 5 Mar 2027; mahadasha Rahu from 9 Feb 2028.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Mithuna (Gemini) | 6°02′ | 12th | Mrigashira 4 |
| Moon | Kanya (Virgo) | 19°49′ | 3rd | Hasta 3 |
| Mars | Makara (Capricorn) | 14°57′ | 7th | Shravana 2 |
| Mercury | Mithuna (Gemini) | 23°07′ | 12th | Punarvasu 1 |
| Jupiter (R) | Tula (Libra) | 19°48′ | 4th | Swati 4 |
| Venus | Karka (Cancer) | 14°48′ | 1st | Pushya 4 |
| Saturn (R) | Dhanu (Sagittarius) | 12°12′ | 6th | Mula 4 |
| Rahu | Karka (Cancer) | 13°43′ | 1st | Pushya 4 |
| Ketu | Makara (Capricorn) | 13°43′ | 7th | Shravana 2 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how XERS moved in each period against the S&P 500, transits, fundamentals and news.